SCHEMBL1720045

SCHEMBL1720045

OC1(c2ccc(F)c(F)c2)CCC2(CC1)OCCO2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 8/20 0.41
SLC6A2 P23975 5/20 0.41
CHRNA1 P02708 1/20 0.41
CHRNG P07510 1/20 0.41
CHRNB1 P11230 1/20 0.41
CHRNB2 P17787 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA4 P43681 1/20 0.41
CHRND Q07001 1/20 0.41
SLC6A4 P31645 7/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 1/20 0.38
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 2/20 0.35
DRD2 P14416 1/20 0.34
HCAR3 P49019 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7782176 0.86 SLC6A3 (0.43) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL23215170 0.86 SLC6A3 (0.47) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL615013 0.82 CYP3A4 (0.38) RAB9APOLBMAPTHTTSMN1; SMN2
SCHEMBL14403245 0.82 DRD2 (0.39) SLC6A3SLC6A4POLBALDH1A1DRD2
SCHEMBL612754 0.81 OPRM1 (0.43) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL17186970 0.81 PDE2A (0.41) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL731991 0.79 OPRL1 (0.49) SLC6A3SLC6A2CHRNA1CHRNB1CHRNB2
SCHEMBL17186929 0.78 SLC6A3 (0.49) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1
SCHEMBL613410 0.77 DRD2 (0.55) SLC6A3SLC6A4POLBMAPTHTT
SCHEMBL15420336 0.77 HDAC3 (0.38) SLC6A3SLC6A2CHRNA1CHRNGCHRNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1888066-B1 AMINOCYCLOHEXANES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES MERCK SHARP & DOHME (US) 2012-01-11 EP disclosed
US-6153611-A AS NON-DOPAMINERGIC ANTIISCHEMIC COMPOUNDS FOR TREATING BRAIN DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2000-11-28 US disclosed
US-5658941-A PSYCHOLOGICAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1997-08-19 US disclosed
EP-0433836-B1 Halophenyl substituted dioxanes HOFFMANN LA ROCHE (CH) 1996-03-27 EP disclosed
US-5496847-A ANXIOLYTIC AND ANTIDEPRESSANT BRISTOL-MYERS SQUIBB CO. (US) 1996-03-05 US disclosed
US-5391570-A Anxiolytic agents; antidepressants BRISTOL-MYERS SQUIBB (US) 1995-02-21 US disclosed
US-5322638-A Halophenyl substituted dioxanes HOFFMANN-LA ROCHE INC. (US) 1994-06-21 US disclosed
EP-0433836-A2 Halophenyl substituted dioxanes F. HOFFMANN-LA ROCHE AG (CH) 1991-06-26 EP disclosed